HealthTech in Asia: Caveat Emptor, Caveat Venditor https://t.co/FNNSm3Rdwk
— The Propell Group (@ThePropellGroup) May 8, 2018
HealthTech in Asia: Caveat Emptor, Caveat Venditor https://t.co/FNNSm3Rdwk
— The Propell Group (@ThePropellGroup) May 8, 2018